Cabaletta Bio (CABA) Short Interest Ratio & Short Volume → Read this before you buy AI stocks (From InvestorPlace) (Ad) Free CABA Stock Alerts $12.50 -0.38 (-2.95%) (As of 11:45 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cabaletta Bio Short Interest DataCurrent Short Interest10,250,000 sharesPrevious Short Interest9,870,000 sharesChange Vs. Previous Month+3.85%Dollar Volume Sold Short$109.11 millionShort Interest Ratio8.9 Days to CoverLast Record DateApril 30, 2024Outstanding Shares48,280,000 sharesPercentage of Shares Shorted21.23%Today's Trading Volume172,251 sharesAverage Trading Volume1,034,699 sharesToday's Volume Vs. Average17% Short Selling Cabaletta Bio ? Sign up to receive the latest short interest report for Cabaletta Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCABA Short Interest Over TimeCABA Days to Cover Over TimeCABA Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Cabaletta Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,250,000 shares $109.11 million +3.9%N/A8.9 $10.65 4/15/20249,870,000 shares $159.70 million +16.1%N/A10.3 $16.18 3/31/20248,500,000 shares $145.01 million +19.9%N/A9 $17.06 3/15/20247,090,000 shares $132.87 million +1.1%N/A7.9 $18.74 2/29/20247,010,000 shares $160.39 million +2.6%N/A7.1 $22.88 2/15/20246,830,000 shares $163.24 million +6.9%N/A5.4 $23.90 Get the Latest News and Ratings for CABA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cabaletta Bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,390,000 shares $130.87 million -0.5%N/A5 $20.48 1/15/20246,420,000 shares $136.10 million +3.2%N/A5.4 $21.20 12/31/20236,220,000 shares $141.19 million +10.5%N/A5.3 $22.70 12/15/20235,630,000 shares $115.70 million -0.7%N/A4.8 $20.55 11/30/20235,670,000 shares $91.00 million +12.1%N/A4.9 $16.05 11/15/20235,060,000 shares $87.89 million -19.4%N/A6.4 $17.37 10/31/20236,280,000 shares $89.55 million +1.5%N/A8.6 $14.26 10/15/20236,190,000 shares $94.83 million +19.3%N/A9.1 $15.32 9/30/20235,190,000 shares $78.99 million +65.3%N/A8 $15.22 9/15/20233,140,000 shares $49.64 million -3.7%N/A5 $15.81 8/31/20233,260,000 shares $46.16 million -39.2%N/A6 $14.16 8/15/20235,360,000 shares $73.27 million +6.1%N/A11.6 $13.67 7/31/20235,050,000 shares $68.78 million -8.4%N/A10.4 $13.62 7/15/20235,510,000 shares $66.73 million +4.8%N/A11 $12.11 6/30/20235,260,000 shares $67.91 million +22.3%N/A11.2 $12.91 6/15/20234,300,000 shares $55.34 million +7.0%N/A9.9 $12.87 5/31/20234,020,000 shares $40.56 million +1.0%N/A11.8 $10.09 5/15/20233,980,000 shares $45.69 million -0.5%N/A11 $11.48 4/30/20234,000,000 shares $41.52 million -1.0%N/A10.3 $10.38 4/15/20234,040,000 shares $31.55 million +9.8%N/A9.3 $7.81 3/31/20233,680,000 shares $30.43 million +3.1%N/A7.2 $8.27 3/15/20233,570,000 shares $26.45 million +2.6%N/A5.5 $7.41 2/28/20233,480,000 shares $30.76 million +3.0%N/A4.6 $8.84 2/15/20233,380,000 shares $27.21 million -0.3%N/A4.2 $8.05 1/31/20233,390,000 shares $41.32 million +3.7%N/A3.9 $12.19 1/15/20233,270,000 shares $32.77 million -7.4%N/A2.6 $10.02 12/30/20223,530,000 shares $32.65 million -0.3%N/A2.6 $9.25 12/15/20223,540,000 shares $23.90 million -3.5%N/A2.7 $6.75 11/30/20223,670,000 shares $16.44 million +6.4%N/A2.8 $4.48 11/15/20223,450,000 shares $12.32 million -8.5%N/A2.3 $3.57 10/31/20223,770,000 shares $6.37 million +5.9%N/A1.9 $1.69 10/15/20223,560,000 shares $3.03 million -23.6%N/A1.8 $0.85 9/30/20224,660,000 shares $3.03 million +11.8%N/A3.5 $0.65 9/15/20224,170,000 shares $3.67 million +21.2%N/A3.2 $0.88Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some 8/31/20223,440,000 shares $3.28 million +55.0%N/A2.8 $0.95 8/15/20222,220,000 shares $3.40 million +8.3%N/A2.4 $1.53 7/31/20222,050,000 shares $2.42 million +4.6%N/A11.3 $1.18 7/15/20221,960,000 shares $3.04 million +6.5%N/A12.2 $1.55 6/30/20221,840,000 shares $1.95 million +0.6%N/A11.4 $1.06 6/15/20221,830,000 shares $1.83 million +1.7%N/A12.2 $1.00 5/31/20221,800,000 shares $2.30 million -1.6%N/A11.2 $1.28 5/15/20221,830,000 shares $2.73 million +2.8%N/A10.3 $1.49 4/30/20221,780,000 shares $2.46 million No ChangeN/A10.1 $1.38 4/15/20221,780,000 shares $3.24 million -2.2%N/A10 $1.82 3/31/20221,820,000 shares $3.69 million No ChangeN/A11 $2.03 3/15/20221,820,000 shares $3.06 million +2.8%N/A8.7 $1.68 2/28/20221,770,000 shares $3.82 million No ChangeN/A3 $2.16 2/15/20221,770,000 shares $5.01 million -0.6%N/A3.1 $2.83 1/31/20221,780,000 shares $5.38 million -1.1%N/A3 $3.02 1/15/20221,800,000 shares $6.17 million -1.1%N/A3 $3.43 12/31/20211,820,000 shares $6.90 million -1.1%N/A3 $3.79 12/15/20211,840,000 shares $7.30 million +1.1%N/A3.1 $3.97 11/30/20211,820,000 shares $21.08 million +10.3%N/A11.1 $11.58 11/15/20211,650,000 shares $19.93 million +22.2%N/A8.1 $12.08 10/29/20211,350,000 shares $18.45 million No ChangeN/A7 $13.67 10/15/20211,350,000 shares $16.55 million No Change8.7%8 $12.26 9/30/20211,350,000 shares $16.42 million +0.8%8.7%9.1 $12.16 9/15/20211,340,000 shares $15.54 million +1.5%8.7%8.2 $11.60 8/31/20211,320,000 shares $13.44 million +0.8%8.9%8.2 $10.18 8/13/20211,310,000 shares $9.77 million -1.5%8.8%11.2 $7.46 7/30/20211,330,000 shares $9.92 million -1.5%8.4%11.4 $7.46 7/15/20211,350,000 shares $10.14 million -1.5%8.5%10.5 $7.51 6/30/20211,370,000 shares $11.78 million -11.6%8.7%10 $8.60 6/15/20211,550,000 shares $12.21 million +1.3%9.8%14.3 $7.88 5/28/20211,530,000 shares $17.35 million -6.1%9.7%15.1 $11.34 5/14/20211,630,000 shares $14.31 million -4.7%12.0%14.9 $8.78 4/30/20211,710,000 shares $19.49 million +1.2%10.4%15.6 $11.40 4/15/20211,690,000 shares $19.01 million -2.9%9.5%15.5 $11.25 3/31/20211,740,000 shares $18.32 million +1.2%9.8%15.9 $10.53 3/15/20211,720,000 shares $20.49 million +5.5%9.7%14.3 $11.91 2/26/20211,630,000 shares $18.17 million +1.2%9.2%13.5 $11.15 2/12/20211,610,000 shares $20.13 million +4.6%9.1%14.9 $12.50 1/29/20211,540,000 shares $19.33 million +4.8%8.7%15.2 $12.55 1/15/20211,470,000 shares $20.02 million +2.8%8.3%15.2 $13.62 12/31/20201,430,000 shares $17.52 million +5.2%8.3%15.9 $12.25 12/15/20201,360,000 shares $20.20 million +4.6%7.8%17.7 $14.85 11/30/20201,300,000 shares $19.54 million +7.4%7.6%18.4 $15.03 11/15/20201,210,000 shares $16.95 million +0.8%7.1%16.4 $14.01 10/30/20201,200,000 shares $14.66 million +2.6%7.1%16 $12.22 10/15/20201,170,000 shares $12.83 million +7.3%6.9%14.2 $10.97 9/30/20201,090,000 shares $11.82 million +11.0%6.4%11.4 $10.84 9/15/2020981,800 shares $11.39 million +4.5%5.8%6.1 $11.60 8/31/2020939,400 shares $9.91 million +4.0%5.5%6.1 $10.55 8/14/2020903,300 shares $10.30 million -21.5%5.3%5.6 $11.40Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some 7/31/20201,150,000 shares $13.14 million +26.6%6.8%6.9 $11.43 7/15/2020908,200 shares $9.96 million -26.8%7.3%5.3 $10.97 6/30/20201,240,000 shares $13.81 million +348.8%9.9%7.6 $11.14 6/15/2020276,300 shares $2.16 million +132.0%2.2%2.8 $7.81 5/29/2020119,100 shares $990,912.00 +21.7%1.0%1.2 $8.32 5/15/202097,900 shares $690,195.00 -19.0%0.8%1.2 $7.05 4/30/2020120,900 shares $876,525.00 +47.3%1.0%1.7 $7.25 4/15/202082,100 shares $569,774.00 +0.4%0.5%1.3 $6.94 3/31/202081,800 shares $522,702.00 -18.9%0.5%1.3 $6.39 3/13/2020100,800 shares $753,984.00 +21.6%0.6%3.7 $7.48 2/28/202082,900 shares $590,248.00 -4.7%0.5%1 $7.12 2/14/202087,000 shares $1.10 million -8.3%0.5%1 $12.66 1/31/202094,900 shares $1.56 million -39.3%0.6%1 $16.44 1/15/2020156,300 shares $2.41 million +0.5%0.9%1.2 $15.42 12/31/2019155,600 shares $2.72 million No Change1.1%1.2 $17.47 CABA Short Interest - Frequently Asked Questions What is Cabaletta Bio's current short interest? Short interest is the volume of Cabaletta Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 10,250,000 shares of CABA short. Learn More on Cabaletta Bio's current short interest. What is a good short interest ratio for Cabaletta Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CABA shares currently have a short interest ratio of 9.0. Learn More on Cabaletta Bio's short interest ratio. Which institutional investors are shorting Cabaletta Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cabaletta Bio: Ikarian Capital LLC, StemPoint Capital LP, HAP Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cabaletta Bio's short interest increasing or decreasing? Cabaletta Bio saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 10,250,000 shares, an increase of 3.9% from the previous total of 9,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cabaletta Bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cabaletta Bio: Alector, Inc. (10.20%), Allogene Therapeutics, Inc. (32.03%), Valneva SE (0.08%), Taysha Gene Therapies, Inc. (9.04%), Fate Therapeutics, Inc. (19.45%), Adaptive Biotechnologies Co. (8.17%), Editas Medicine, Inc. (24.93%), Voyager Therapeutics, Inc. (7.74%), iTeos Therapeutics, Inc. (7.23%), Exscientia plc (3.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cabaletta Bio stock? Short selling CABA is an investing strategy that aims to generate trading profit from Cabaletta Bio as its price is falling. CABA shares are trading up $0.53 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cabaletta Bio? A short squeeze for Cabaletta Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CABA, which in turn drives the price of the stock up even further. How often is Cabaletta Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CABA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Alector Short Interest Data Allogene Therapeutics Short Interest Data Valneva Short Interest Data Taysha Gene Therapies Short Interest Data Fate Therapeutics Short Interest Data Adaptive Biotechnologies Short Interest Data Editas Medicine Short Interest Data Voyager Therapeutics Short Interest Data iTeos Therapeutics Short Interest Data Exscientia Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CABA) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersNext President (Not Trump. Not Biden.)The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsDoes this make you sick?Allegiance Gold[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold